The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing first line tyrosine kinase or checkpoint inhibitor therapy.
 
Michael Staehler
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; EMD Serono; EUSA Pharma; Exelixis; Incyte; Ipsen; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Apogepha; AstraZeneca; Bristol-Myers Squibb; Eisai; EMD Serono; EUSA Pharma; Exelixis; Ipsen; Johnson & Johnson/Janssen; Merck Sharp & Dohme; Novartis; Oncorena; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Novartis; Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Eisai; EMD Serono; EUSA Pharma; Ipsen; MSD Oncology; Novartis; Pfizer
 
Sophie Kunte
No Relationships to Disclose
 
Adrien Holzgreve
Honoraria - ABX advanced biochemical compounds.
 
Marcus Unterrainer
No Relationships to Disclose
 
Iulia Blajan
No Relationships to Disclose
 
Christian Stief
No Relationships to Disclose
 
Peter Bartenstein
No Relationships to Disclose
 
Jozefina Casuscelli
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Expert Testimony - Astellas Pharma; Janssen Cilag; MSD Oncology
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Merck KGaA; Pfizer
 
Lena Unterrainer
Honoraria - ABX advanced biochemical compounds.